Molecular subtypes of pancreatic cancer

Collisson, Eric A., Bailey, Peter, Chang, David K., Biankin, Andrew V.·2019·Nature Reviews Gastroenterology & Hepatology

DOI 10.1038/s41575-019-0109-y

Cited by (895)

Items 401–500 of 895

Tumor-Intrinsic Kinome Landscape of Pancreatic Cancer Reveals New Therapeutic Approaches
Yi Xu, Xianlu L. Peng, Michael P. East, Ian C. McCabe, Grace C. Stroman, Madison R. Jenner, P. Chan, Ashley B. Morrison, Emily C. Shen, Silvia G. Hererra et al. · 2024 · Cancer Discovery
Pancreatic cancer subtyping - the keystone of precision treatment
Zeyang Fan, Yao Xiao, Yan Du, Yan Zhang, Wence Zhou · 2025 · Frontiers in Immunology
Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations
Philipp Hafner, Steffen Johannes Keller, Xun Chen, Asma Y. Alrawashdeh, Huda Jumaa, Friederike Inga Nollmann, Solène Besson, Judith Kemming, Oliver Gorka, Tonmoy Das et al. · 2026 · Signal Transduction and Targeted Therapy
Integrated and Comprehensive Diagnostics: An Emerging Paradigm in Precision Oncology
Kakoli Das, Jens Samol, Irfan Sagir Khan, Bernard Chi Shern Ho, Khoon Leong Chuah · 2026 · Cancers
Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer
Wenzhe Gao, Dongjie Chen, Jixing Liu, Longjun Zang, Tijun Xiao, Xianlin Zhang, Zheng Li, Hongwei Zhu, Xiao Yu · 2022 · Frontiers in Immunology
Circ_0058058 Drives the Malignant Phenotypes and Immune Evasion of Pancreatic Cancer by the MicroRNA-557–Dependent Regulation of PDL1
Lin Lin, Liang Xiao, Chang’e Jin, Ying� Qin, Haoyuan Deng, Meixiang Li, Huan Lin, Xuehao Gong · 2022 · Pancreas
Ex vivo modeling of acquired drug resistance in BRAF - mutated pancreatic cancer organoids uncovers individual therapeutic vulnerabilities
Sabrina Steiner, Alicia Pliego‐Mendieta, Martina Haberecker, Saskia Hussung, Anna Kollár, Ralph Fritsch, Fabian M. Arnold, Daniela M. Lenggenhager, Lara Planas‐Paz, Chantal Pauli · 2024 · Cancer Letters
Cholesterol Biosynthesis Influences Subtype Specificity and Plasticity in Pancreas Cancer
Sita Kugel, Sunil R. Hingorani · 2020 · Cancer Cell
Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma
Shubham Gupta, Sikandar Khan, Michal Kawka, Rohan R Gujjuri, Ian Chau, Naureen Starling, David Cunningham, Long R. Jiao, Tamara Gall · 2021 · Expert Review of Gastroenterology & Hepatology
De novo expression of gastrokines in pancreatic precursor lesions impede the development of pancreatic cancer
Sabrina Steiner, Gitta Maria Seleznik, Theresia Reding, Matea Stopic, Daniela M. Lenggenhager, Emiel B. J. ten Buren, Dilmurodjon Eshmuminov, Katharina Endhardt, Catherine Hagedorn, Anna M. Heidenblut et al. · 2022 · Oncogene
Pre-Training on In Vitro and Fine-Tuning on Patient-Derived Data Improves Deep Neural Networks for Anti-Cancer Drug-Sensitivity Prediction
Paul Prasse, Pascal Iversen, Matthias Lienhard, Kristina Thedinga, Ralf Herwig, Tobias Scheffer · 2022 · Cancers
Pancreatic ductal adenocarcinoma holds unique features to form an immunosuppressive microenvironment: a narrative review
Qiang Zhou, Dan Chen, Junfeng Zhang, Ji-Feng Xiang, Tao Zhang, Huaizhi Wang, Yanyan Zhang · 2022 · Journal of Pancreatology
A Novel Molecular Signature of Cancer-Associated Fibroblasts Predicts Prognosis and Immunotherapy Response in Pancreatic Cancer
Weiyu Ge, Ming Yue, Yanling Wang, Yongchao Wang, Shengbai Xue, Daiyuan Shentu, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Shumin Li et al. · 2022 · International Journal of Molecular Sciences
RAS and Other Molecular Targets in Pancreatic Cancer: The Next Wave Is Coming
Lisa Miller‐Phillips, Eric Andrew Collisson · 2023 · Current Treatment Options in Oncology
APOL3-LDHA axis related immunity activation and cancer ferroptosis induction
Yuzhao Feng, Yunlu Dai · 2023 · International Journal of Biological Sciences
Evidence for molecular subtyping in pancreatic ductal adenocarcinoma: a systematic review
Francis P. Robertson, Andrew J. Cameron, Harry V. M. Spiers, Nejo Joseph, Ellie Taylor, Bathiya Ratnayake, Nigel Balfour Jamieson, Sanjay Pandanaboyana · 2024 · HPB
RAS-RAF-miR-296-3p signaling axis increases Rad18 expression to augment radioresistance in pancreatic and thyroid cancers
Adam R. Wolfe, Haihua Feng, Oscar Zuniga, Henrique Rodrigues, Daniel E. Eldridge, Linlin Yang, Changxian Shen, Terence Marques Williams · 2023 · Cancer Letters
Integrated immuno-transcriptomic analysis of ovarian cancer identifies a four-chemokine-dominated subtype with antitumor immune-active phenotype and favorable prognosis
Lili Zhuo, Fanling Meng, Kaidi Sun, Meng Zhou, Jie Sun · 2024 · British Journal of Cancer
Heterogeneity-preserving discriminative feature selection for disease-specific subtype discovery
Abdur Rahman M. A. Basher, Caleb Hallinan, Kwonmoo Lee · 2025 · Nature Communications
The dual role of ferroptosis in pancreatic cancer: a narrative review
Daolin Tang, Xin Chen, Paul Burdett Comish, Rui Kang · 2021 · Journal of Pancreatology
Computing microRNA-gene interaction networks in pan-cancer using miRDriver
Banabithi Bose, Matthew Moravec, Serdar Bozdag · 2022 · Scientific Reports
Correlation of transcriptional subtypes with a validated CT radiomics score in resectable pancreatic ductal adenocarcinoma
Emmanuel Salinas-Miranda, Gerard M. Healy, Barbara T. Grünwald, Rahi Jain, Dominik Deniffel, Grainne Mary O'Kane, Robert C. Grant, Julie M. Wilson, Jennifer Jane Knox, Steve Gallinger et al. · 2022 · European Radiology
The expression characteristics of transmembrane protein genes in pancreatic ductal adenocarcinoma through comprehensive analysis of bulk and single-cell RNA sequence
Chen Ye, Siqian Ren, Abuduhaibaier Sadula, Xin Guo, Yuan Meng, Meng Meng, Gang Li, Xiaowei Zhang, Chunhui Yuan · 2023 · Frontiers in Oncology
Prediction of risk and overall survival of pancreatic cancer from blood soluble immune checkpoint-related proteins
Sai Pan, Wenting Zhao, Yizhan Li, Zhijun Ying, Yihong Luo, Qinchuan Wang, Xiawei Li, Wenjie Lu, Xin Dong, Yulian Wu et al. · 2023 · Frontiers in Immunology
Multiplexed Imaging Mass Cytometry Analysis in Preclinical Models of Pancreatic Cancer
Marco Erreni, Maria Rita Fumagalli, Damiano Zanini, Ermes Candiello, Giorgia Tiberi, Raffaella Parente, Raffaella D’Anna, Elena Illica Magrini, Federica Marchesi, Paola Cappello et al. · 2024 · International Journal of Molecular Sciences
Cell of Origin of Pancreatic cancer
Chenlei Zheng, Jianing Wang, Junli Wang, Qi Zhang, Tingbo Liang · 2024 · Pancreas
LMO3 is a suppressor of the basal-like/squamous subtype and reduces disease aggressiveness of pancreatic cancer through glycerol 3-phosphate metabolism
Yuuki Ohara, Amanda J. Craig, Huaitian Liu, S. S. Yang, Paloma Moreno, Tiffany H. Dorsey, Helen Cawley, Azadeh Azizian, Jochen Gaedcke, Michael B. Ghadimi et al. · 2024 · Carcinogenesis
Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma
Lyanne Delgado Coka, Lucia Roa‐Peña, Sruthi Babu, Michael Horowitz, Emanuel F. Petricoin, Lynn McCormick Matrisian, Edik Matthew Blais, Natalia D. Marchenko, Felicia D. Allard, Ali Akalin et al. · 2024 · American Journal of Clinical Pathology
Eravacycline, an antibacterial drug, repurposed for pancreatic cancer therapy: insights from a molecular-based deep learning model
Adi Jabarin, Guy Shtar, Valeria Feinshtein, Eyal Mazuz, Bracha Shapira, Shimon Ben‐Shabat, Lior Rokach · 2024 · Briefings in Bioinformatics
Comprehensive Analysis of LincRNAs in Classical and Basal-Like Subtypes of Pancreatic Cancer
Markus Glaß, Ágnes Dorn, Stefan Hüttelmaier, Monika Hämmerle, Tony Gutschner · 2020 · Cancers
Targeting TAM to Tame Pancreatic Cancer
Mitchell S. von Itzstein, Michael Burke, Rolf A. Brekken, Todd Anthony Aguilera, Herbert J. Zeh, Muhammad Shaalan Beg · 2020 · Targeted Oncology
Ten‐year experience in optimizing neoadjuvant therapy for localized pancreatic cancer—Medical college of Wisconsin perspective
Erin P. Ward, Douglas B. Evans, Susan Tsai · 2021 · Journal of Surgical Oncology
Charged Particle Irradiation for Pancreatic Cancer: A Systematic Review of In Vitro Studies
Dandan Wang, Ruifeng Liu, Qiuning Zhang, Hongtao Luo, Junru Chen, Meng Dong, Yuhang Wang, Yuhong Ou, Zhiqiang Liu, Shilong Sun et al. · 2022 · Frontiers in Oncology
Consensus Statement on Mandatory Measurements for Pancreatic Cancer Trials for Patients With Resectable or Borderline Resectable Disease (COMM-PACT-RB)
Esther N. Pijnappel, José Annelie Suurmeijer, Bas Groot Koerkamp, Milan Kos, Jens Thomas Siveke, Roberto Salvia, Paula Ghaneh, Casper H.J. van Eijck, Faridi S. van Etten‐Jamaludin, Ross Allen Abrams et al. · 2022 · JAMA Oncology
Emerging Role for 7T MRI and Metabolic Imaging for Pancreatic and Liver Cancer
Debra S. Rivera · 2022 · Metabolites
Identification of Prognosis-Related Molecular Subgroups and Construction of a Prognostic Prediction Model Using Immune-Related Genes in Pancreatic Cancer
Xiang Fei, Lingming Kong, Chao Shi, Gang Wang, Chenhai Liu, Cheng Wang, Peng Liu, Xiaodong Tan · 2022 · Journal of Oncology
Invasive IPMN relapse later and more often in lungs in comparison to pancreatic ductal adenocarcinoma
Giovanni Luigi Capretti, Martina Nebbia, Francesca Gavazzi, Gennaro Nappo, Cristina Ridolfi, Mauro Sollai, Paola Spaggiari, Silvia Bozzarelli, Silvia Carrara, Antonio Luberto et al. · 2022 · Pancreatology
p53 inhibitor iASPP is an unexpected suppressor of KRAS and inflammation-driven pancreatic cancer
Paul Miller, Elliot H. Akama‐Garren, Richard Peter Owen, Constantinos Demetriou, Thomas M. Carroll, Elizabeth A. Slee, Khatoun Al Moussawi, Michael Ellis, Robert David Goldin, Eric E. O’Neill et al. · 2023 · Cell Death and Differentiation
Systematic Analysis of Alternative Splicing Landscape in Pancreatic Adenocarcinoma Reveals Regulatory Network Associated with Tumorigenesis and Immune Response
Jiahua Lu, Shenyu Wei, Jianying Lou, Shengyong Yin, Lin Zhou, Wu Zhang, Shusen Zheng · 2020 · Medical Science Monitor
Pancreatic cancer driver mutations are targetable through distant alternative RNA splicing dependencies
Ryan R. Kawalerski, Steven D. Leach, Luisa F. Escobar‐Hoyos · 2021 · Oncotarget
The implication of liquid biopsies to predict chemoresistance in pancreatic cancer
Elisabetta Pietri, Rita Balsano, Matilde Corianò, Fabio Gelsomino, Francesco Leonardi, Simona Bui, Letizia Gnetti, Raffaele Dalla Valle, Ingrid Garajová · 2021 · Cancer Drug Resistance
Molecular Subtypes of Pancreatic Cancer: A Proteomics Approach
Ravi Kumar Thakur, Pankaj K. Singh · 2021 · Clinical Cancer Research
lncRNAs: potential therapeutic targets and biomarkers for pancreatic cancer?
Marta Montes, Luís Arnes · 2021 · Expert Opinion on Therapeutic Targets
Ras-dependent activation of BMAL2 regulates hypoxic metabolism in pancreatic cancer
Alvaro Curiel-Garcia, Sam R. Holmstrom, Cristina Castillo, Carmine F. Palermo, Stephen A. Sastra, Anthony C. Andren, Lorenzo Tomassoni, Li Zhang, Tessa Y. S. Le Large, Irina R. Sagalovskiy et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
Metabolomic Approach to Identify Potential Biomarkers in KRAS-Mutant Pancreatic Cancer Cells
Boyun Kim, Jewon Jung · 2024 · Biomedicines
Dual and triple gene combinations of KRT5 , KRT17 , and S100A2 identify basal‐like subtype of pancreatic ductal adenocarcinoma and correlate with survival outcome
Qiangxing Chen, Zixin Chen, Jing Zhang, Yunqiang Cai, Shangdi Wu, Du He, Ke Cheng, Xiafei Gu, Yu Cai, Xin Wang et al. · 2024 · The FASEB Journal
The complement C3a/C3aR pathway is associated with treatment resistance to gemcitabine-based neoadjuvant therapy in pancreatic cancer
Saimeng Shi, Long‐Yun Ye, Kaizhou Jin, Xianjun Yu, Duancheng Guo, Weiding Wu · 2024 · Computational and Structural Biotechnology Journal
Deciphering riddles in molecular subtyping of bladder cancer
Yuxiao Li, Suyuelin Huang, Wenlong Ju, Dingheng Lu, Jiazhu Sun, Weitao Zhan, Xinyang Niu, Yuchen Shi, Kai Yu, Ben Liu · 2024 · Asian journal of urology
Stress and Obesity Signaling Converge on CREB Phosphorylation to Promote Pancreatic Cancer
Xiaoying Sun, Yaroslav Teper, James W. Sinnett‐Smith, Mineh Markarian, Oscar Joe Hines, Gang Li, Guido Eibl, Enrique Rozengurt · 2024 · Molecular Cancer Research
Multidimensional analyses identify genes of high priority for pancreatic cancer research
Zeribe C. Nwosu, Heather M. Giza, Maya Nassif, Verodia Charlestin, Rosa Elena Menjivar, Dae-Ho Kim, Samantha B. Kemp, Peter Sajjakulnukit, Anthony C. Andren, Li Zhang et al. · 2025 · JCI Insight
Serum proteomics reveals survival-associated biomarkers in pancreatic cancer patients treated with chemoimmunotherapy
Marco Tognetti, Lopamudra Chatterjee, Nigel Beaton, Kamil Skłodowski, Roland Bruderer, Lukas Reiter, Christoph B. Messner · 2025 · iScience
Single-Molecule Liquid Biopsy Detects Low- and High-Abundance Protein Markers Simultaneously for Pancreatic Cancer Diagnosis
Xinjian Wang, Yudong Che, Songlin Liu, Bochen Ma, Yijun Liu, Jiao Lei, Liang Yuan, Yiwen Zhou, Jieer Ying, Yimin Zhang et al. · 2025 · Analytical Chemistry
HMGA2 and protein leucine methylation drive pancreatic cancer lineage plasticity
Stephanie Dobersch, Naomi Yamamoto, Aidan Schutter, Sarah M. Cavender, Tess M. Robertson, Nithya Kartha, Annie N. Samraj, Ben Doron, Lisa A. Poole, Cynthia L. Wladyka et al. · 2025 · Nature Communications
A biomaterial-based platform of pancreatic cancer reveals kallikrein-related peptidase 6 (KLK6) as a mediator of neutrophil recruitment and immunosuppression
Verena Kast, Sandra Hauser, Ali Nadernezhad, Dagmar Pette, Manfred F. Maitz, Andreas Petzold, Andreas Dahl, Michael Seifert, Katja Eubler, Artur Mayerhofer et al. · 2025 · Biomaterials
Cannabichromene: integrative modulation of apoptosis, ferroptosis, and endocannabinoid signaling in pancreatic cancer therapy
Yu-Na Hwang, Ju-Hee Park, Han-Heom Na, Tae-Hyung Kwon, Jin-Sung Park, Sehyun Chae, Young Taek Oh, Keun‐Cheol Kim · 2025 · Cell Death Discovery
Integrative genomic identification of therapeutic targets for pancreatic cancer
Jimmy A. Guo, Dennis H. Gong, Kyle E. Evans, Kazuki Takahashi, Ananya D. Jambhale, Carina Shiau, Patrick Z. Yu, Steven Wang, Wenzhuo Wu, Seema Chugh et al. · 2025 · Cell Reports
An injury-associated lobular microniche is associated with the classical tumor cell phenotype in pancreatic cancer
Sara Söderqvist, Annika Viljamaa, Natalie Geyer, Anna‐Lena Keller, Kseniya Ruksha, Carina Strell, Neda Hekmati, Alexandra Niculae, Jennie Engstrand, Ernesto Sparrelid et al. · 2025 · Nature Communications
Multilevel Regulation of NF‐κB Signaling by NSD2 Suppresses Kras‐Driven Pancreatic Tumorigenesis
Wen-Xin Feng, Ning-Ning Niu, Ping Lu, Zhuo Chen, Han-Yu Rao, Wei Zhang, Chunxiao Ma, Changwei Liu, Yue Xu, Wei-Qiang Gao et al. · 2023 · bioRxiv
Synchronous arterial resections in pancreatic cancer – still a matter of debate?
Savio George Barreto, Jorg H. Kleeff · 2020 · European Journal of Surgical Oncology
RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets
Shao‐Long Chen, Guoping Wang, Danrong Shi, Shu-Hao Yao, Keda Chen, Hangping Yao · 2021 · World Journal of Gastroenterology
Beyond the Front Line: Emerging Data for Maintenance Therapy in Pancreatic Cancer
Harshabad Singh, Kimberly J. Perez, Brian Matthew Wolpin, Andrew J. Aguirre · 2021 · Journal of Clinical Oncology
Age-related Survival Outcomes for Pancreatic Cancer by Age
Ali Abbaszadeh Kasbi, Mohammed Ali Ashary, Mizba Baksh, S A Nussbaum, Kristopher M. Attwood, Emmanuel M Gabriel · 2022 · Cancer Diagnosis & Prognosis
Sample-Specific Perturbation of Gene Interactions Identifies Pancreatic Cancer Subtypes
Ran Wei, Huihui Zhang, Jianzhong Cao, Dailei Qin, Shengping Li, Wuguo Deng · 2022 · International Journal of Molecular Sciences
Exploring the Potential of Pyroptosis-Related Genes in Predicting Prognosis and Immunological Characteristics of Pancreatic Cancer From the Perspective of Genome and Transcriptome
Jing Zhang, Xiaomin You, Dong Kang, Guoxiong Zhou · 2022 · Frontiers in Oncology
An ultra-small bispecific protein augments tumor penetration and treatment for pancreatic cancer
Qian Wang, Jingyun Wang, Hao Yan, Zheng Li, Kun Wang, Feiyu Kang, Jie Tian, Xinming Zhao, Seok Hyun Yun · 2023 · European Journal of Nuclear Medicine and Molecular Imaging
Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: Current evidence and new perspectives
de Scordilli, Marco, Michelotti, Anna, Zara, Diego, Palmero, Lorenza, Alberti, Martina, Noto, Claudia, Totaro, Fabiana, Foltran, Luisa, Guardascione, Michela, Iacono, Donatella et al. · 2023 · Critical Reviews in Oncology/Hematology
PancrESS – a meta-analysis resource for understanding cell-type specific expression in the human pancreas
David M. Sturgill, Lı Wang, H. Efsun Arda · 2024 · BMC Genomics
Development and validation of a novel disulfidptosis-related lncRNAs signature in patients with HPV-negative oral squamous cell carcinoma
Fan Yang, Xinyu Niu, Mingzhu Zhou, Wei Li · 2024 · Scientific Reports
Integrating metabolic profiling of pancreatic juice with transcriptomic analysis of pancreatic cancer tissue identifies distinct clinical subgroups
Alessandra Pulvirenti, Marialuisa Barbagallo, Anna Rita Putignano, Antonio Pea, Rebecca Polidori, Rosanna Upstill‐Goddard, Nina Cortese, Paolo Kunderfranco, Laura Brunelli, Giulia De Simone et al. · 2024 · Frontiers in Oncology
The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtyping in Pancreatic Cancer
Michael Guenther, Sai Agash Surendran, Leah Steinke, Iduna Liou, Melanie Alexandra Palm, Volker Heinemann, Michael Haas, Stefan Hubert Boeck, Steffen Ormanns · 2025 · Biomolecules
Navigating the complexities of pancreatic ductal adenocarcinoma: A review on therapeutic models and RAS inhibitors
Sara Barrambana, Elena Zamorano-Domínguez, Vasiliki Liaki, Carmen E. Guerra · 2025 · Advanced Drug Delivery Reviews
Pathway-Specific Genomic Alterations in Pancreatic Cancer Across Populations at Risk
Cecilia Monge, Brigette Waldrup, Francisco Carranza, Sophia Manjarrez, Enrique I. Velazquez-Villarreal · 2025 · International Journal of Molecular Sciences
Integrated spatial morpho-transcriptomics predicts functional traits in pancreatic cancer
Dennis Gong, Rachel Liu, Yi Cui, Michael Rhodes, Jung Woo Bae, J. Beechem, W. L. Hwang · 2025 · Science Advances
EPS8L3 promotes pancreatic cancer proliferation and metastasis by activating GSK3B
Zun Fan, Ming Li, Yinjie Xu, Chenxing Ge, Gu Jianfeng · 2022 · Journal of Medical Biochemistry
Neoadjuvant treatment for pancreatic cancer: Controversies and advances
Douglas Dias e Silva, Vincent M. Chung · 2024 · Cancer Treatment and Research Communications
Construction of S100 family members prognosis prediction model and analysis of immune microenvironment landscape at single-cell level in pancreatic adenocarcinoma: a tumor marker prognostic study
Zijin Xu, Jianang Li, Ze-yuan Cao, Huaxiang Xu, Ying Ying, Zhi-hang Xu, Run-jie Liu, Yuquan Guo, Zixin Zhang, Wenquan Wang et al. · 2024 · International Journal of Surgery
Integrated chromosomal instability and tumor microbiome redefined prognosis-related subtypes of pancreatic cancer
Ruihan Chen, Jiaying Cao, Shi Feng, Haitao Huang, Yimou Lin, Jingyu Jiang, Xuewen Yi, Qi Ling · 2024 · Hepatobiliary & pancreatic diseases international
Minimally invasive determination of pancreatic ductal adenocarcinoma ( PDAC ) subtype by means of circulating cell‐free RNA
Martin Metzenmacher, Gregor Zaun, Marija Trajkovic‐Arsic, Phyllis F. Cheung, Timm M. Reißig, Hendrik Schürmann, Nils v. Neuhoff, Grainne Mary O'Kane, Stephanie Ramotar, Anna Dodd et al. · 2024 · Molecular Oncology
Blocking the road to de‐differentiation: HNF1A/KDM6A complex safeguards epithelial integrity in pancreatic cancer
Stefanie Bärthel, Günter Schneider, Dieter Saur · 2020 · The EMBO Journal
Proteomic analysis of pancreatic ductal adenocarcinoma
Paula Meleady, Rozana Abdul Rahman, Michael A. Henry, Michael J. Moriarty, MARTIN M. CLYNES · 2020 · Expert Review of Proteomics
Clinical practice guidelines for the interventional treatment of advanced pancreatic cancer (5th edition)
Maoquan Li · 2021 · Journal of interventional medicine
DECONbench: a benchmarking platform dedicated to deconvolution methods for tumor heterogeneity quantification
Clémentine Decamps, A Arnaud, Florent Petitprez, Mira Ayadi, Aurélia Baurès, Lucile Armenoult, Nicolas Alcala, A Arnaud, Francisco Avila Cobos, Luciana Batista et al. · 2021 · BMC Bioinformatics
A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
Weiyu Ge, Daiyuan Shentu, Yongchao Wang, Yanling Wang, Shengbai Xue, Ming Yue, Tiebo Mao, Xiaofei Zhang, Haiyan Xu, Shumin Li et al. · 2022 · Frontiers in Cell and Developmental Biology
Systems biology and OMIC data integration to understand gastrointestinal cancers
Iasmin Moreira Costa Bispo, Henry Paul Granger-Neto, Palloma Porto Almeida, Patrícia Belini Nishiyama, Leandro Martins de Freitas · 2022 · World Journal of Clinical Oncology
Anti‑silencing function 1B promotes the progression of pancreatic cancer by activating c‑Myc
Min Zhang, Luyang Zhang, Minghe Zhou, Enze Wang, Bo Meng, Qingjun Li, Xiaoqian Wang, Yunjian Wang, Qiong Li · 2022 · International Journal of Oncology
Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancer
Longjun Zang, Baoming Zhang, Yanling Zhou, Fusheng Zhang, Xiaodong Tian, Zhongming Tian, Dongjie Chen, Qingwang Miao · 2023 · Aging
A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study
Chuan Liu, Xiaofei Cheng, Kai Han, Libing Hong, Shuqiang Hao, Xuqi Sun, XU Jing-feng, Benfeng Li, Dongqing Jin, Weihong Tian et al. · 2024 · Cancer Letters
Establishment, characterization, and biobanking of 36 pancreatic cancer organoids: prediction of metastasis in resectable pancreatic cancer
Soon‐Chan Kim, Ha‐Young Seo, Ja-Oh Lee, Ju Eun Maeng, Young‐Kyoung Shin, Sang Hyub Lee, Jin‐Young Jang, Ja‐Lok Ku · 2024 · Cellular Oncology
Genomics and proteomics to determine novel molecular subtypes and predict the response to immunotherapy and the effect of bevacizumab in glioblastoma
Dongdong Luo, Aiping Luo, Su Hu, Ganwei Ye, Dan Li, Hailin Zhao, Biao Peng · 2024 · Scientific Reports
CpG Island Methylator Phenotype Modulates the Immune Response of the Tumor Microenvironment and Influences the Prognosis of Pancreatic Cancer Patients
Gang Ning, Yongqiang Li, Wenji Chen, Wenjuan Tang, Diwen Shou, Qingling Luo, Huiting Chen, Yongjian Zhou · 2021 · Journal of Oncology
Leveraging Tumor Microenvironment Infiltration in Pancreatic Cancer to Identify Gene Signatures Related to Prognosis and Immunotherapy Response
Jiabin Yang, Liangtang Zeng, Ruiwan Chen, Leyi Huang, Zhuo Kui Wu, Min Yu, Yu Zhou, Rufu Chen · 2023 · Cancers
Pancreatic cancer epigenetics: adaptive metabolism reprograms starving primary tumors for widespread metastatic outgrowth
Arnaldo Franco, Jeffrey Duryea, Oliver Gene McDonald · 2023 · Cancer and Metastasis Reviews
Therapy-associated remodeling of pancreatic cancer revealed by single-cell spatial transcriptomics and optimal transport analysis
Carina Shiau, Jingyi Cao, Mark Gregory, Dennis H. Gong, Xunqin Yin, Jae-Won Cho, Peter L. Wang, Jennifer Su, Steven Wang, Jason Reeves et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
The Prognostic and Immune Significance of CILP2 in Pan-Cancer and Its Relationship with the Progression of Pancreatic Cancer
Danxi Liu, Cong He, Zonglin Liu, Licheng Xu, Jiacheng Li, Zhongjie Zhao, Xuewei Hu, Hua Chen, Bei Sun, Yongwei Wang · 2023 · Cancers
Systematic analysis of proteome turnover in an organoid model of pancreatic cancer by dSILO
Alison B. Ross, Darvesh Gorhe, Jenny Kim Kim, Stefanie J. Hodapp, Lela DeVine, Karina M. Chan, Iok In Christine Chio, Marko Jovanović, Marina Ayres Pereira · 2024 · Cell Reports Methods
Therapeutic targets in the pancreatic adenocarcinoma microenvironment: past challenges and opportunities for the future
Erica S. Tsang, Margaret A. Tempero · 2021 · Journal of Cancer Metastasis and Treatment
ABHD17C, a metabolic and immune-related gene signature, predicts prognosis and anti-PD1 therapy response in pancreatic cancer
Weihao Zhang, Yongjie Xie, Xin Yu, Changfu Liu, Wei Gao, Wenge Xing, Tongguo Si · 2023 · Discover Oncology
GCNA-Cluster: A Gene Co-Expression Network Alignment to Cluster Cancer Patients Algorithm for Identifying Subtypes of Pancreatic Ductal Adenocarcinoma
Jing Yang, Zhengshu Lu, Chen Xu, Deling Xu, Dewu Ding, Yanrui Ding · 2023 · IEEE Transactions on Computational Biology and Bioinformatics
Machine Learning-Based Model Helps to Decide which Patients May Benefit from Pancreatoduodenectomy
Emanuel Vigia, Luís Ramalhete, Edite Filipe, Luís Bicho, Ana Marta Nobre, Paulo Mira, Maria Macedo, Catarina Aguiar, Sofia Costa Corado, Beatriz Chumbinho et al. · 2023 · Onco
Identification of CAF-related lncRNAs at the pan-cancer level represents a potential carcinogenic risk
Ming‐Wei Wang, Minghui Jiang, Aimin Xie, Nan Zhang, Yan Xu · 2024 · Human Molecular Genetics